KALA BIO, Inc. (KALA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, KALA BIO, Inc. reported revenue of $0. The company ran a net loss. It held $9.49M in total assets against $2.49M in total liabilities.
Key ratios (FY2025)
-385.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $3.89M | $11.24M | $6.36M | $6.07M | — | — | — |
| Operating Income | -$39.16M | -$40.98M | -$39.66M | -$81.71M | -$130.25M | -$96.23M | -$88.22M | -$64.72M | -$39.88M | -$32.67M |
| Net Income | -$26.98M | -$38.51M | -$42.20M | -$44.82M | -$142.60M | -$104.33M | -$94.35M | -$66.74M | -$42.21M | -$33.17M |
| EPS (Diluted) | $-3.31 | $-10.15 | $-17.35 | $-29.48 | $-108.32 | $-1.99 | — | — | — | — |
| Total Assets | $9.49M | $55.48M | $55.95M | $86.82M | $139.43M | $221.61M | $154.32M | $220.97M | $116.55M | $46.33M |
| Total Liabilities | $2.49M | $43.15M | $48.45M | $67.85M | $122.62M | $121.61M | $124.63M | $115.99M | $26.87M | $15.70M |
| Shareholders' Equity | $7.00M | $12.33M | $7.50M | $18.97M | $16.80M | $100.00M | $29.69M | $104.98M | $89.68M | -$87.76M |
| Cash & Equivalents | $7.56M | $51.18M | $50.90M | $70.50M | $92.14M | $77.26M | $85.45M | — | — | — |
| Operating Cash Flow | -$31.99M | -$29.38M | -$27.93M | -$78.91M | -$108.23M | -$90.69M | -$92.72M | -$54.12M | -$34.10M | -$27.35M |
| Capital Expenditures | — | — | — | — | — | — | $1.33M | $1.58M | $480.0K | $153.0K |
| Shares Outstanding | 27.85M | 6.09M | 2.76M | 1.71M | 1.32M | 58.92M | 36.09M | 33.86M | 24.54M | 1.18M |